Truist raises Palomar Holdings stock price target on earnings growth

Truist raised its Palomar Holdings price target to $175 from $168 and maintained a Buy rating, lifting its 2026 EPS estimate to $10.40 from $10.20 and its 2027 estimate to $12.00 from $11.65. Truist said the premium valuation is supported by growth and earnings outperformance; revenue rose 58% over the last 12 months and return on equity was 23%. Separately, Palomar’s reported Q3 2026 adjusted EPS of $3.01 exceeded the $2.55 forecast, while revenue of $767 million topped the $754.6 million estimate, and the company raised full-year adjusted net income guidance.

Analysis

The estimate changes are incremental; the more important question is whether Palomar can convert rapid premium growth into durable, risk-adjusted earnings without taking on disproportionate catastrophe exposure or paying up for reinsurance. A growth-driven multiple premium is vulnerable if expansion comes with weaker pricing, adverse mix, reserve strengthening, or greater capital needs. The reported beat is not enough to distinguish underwriting improvement from timing or reserve effects; verify underlying loss and expense ratios, catastrophe losses, reserve development, and exposure growth before treating it as a higher-quality earnings run rate.

Near term, the analyst revision may support sentiment, but it is not by itself a strong catalyst: the implied valuation upside is sensitive to execution and the article provides no independent evidence of improved underwriting economics. Over 1–3 months, earnings detail and reinsurance renewal terms are more informative. Over 6–18 months, catastrophe frequency/severity, property pricing, and reinsurance capacity could determine whether growth compounds or amplifies earnings volatility. The contrarian risk is that investors extrapolate recent growth and EPS beats while underweighting the tail-risk and capital required to sustain them.

Key Decisions for Investors

• Do not chase solely on the target-price increase. Treat PLMR as a conditional growth position: add only after confirming underwriting margins and reserve development support the earnings trajectory.
• Ahead of the next results, monitor catastrophe-adjusted loss ratios, reserve development, premium growth by line/geography, and reinsurance renewal pricing/retentions. These are the missing data needed to judge earnings quality and downside sensitivity.
• Falsify the long thesis if guidance or estimates are cut because of deteriorating loss experience, reserve strengthening, materially higher reinsurance costs, or growth that outpaces available capital; reassess promptly rather than relying on headline EPS growth.
• No compelling pair trade is established by this article alone: it offers neither comparable peer valuations nor underwriting metrics. Revisit relative-value exposure only after comparing PLMR with specialty P&C peers on growth-adjusted returns and catastrophe-adjusted underwriting.